Crossmark

Umbelliferone alleviates hepatic ischemia/reperfusion-induced oxidative stress injury via targeting Keap-1/Nrf-2/ARE and TLR4/NF-κB-p65 signaling pathway

Crossref DOI link: https://doi.org/10.1007/s11356-021-15184-8

Published Online: 2021-07-15

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hassanein, Emad H. M.

Khader, Heba F.

Elmansy, Rasha A.

Seleem, Hanan S.

Elfiky, Mohamed

Mohammedsaleh, Zuhair M.

Ali, Fares E. M. http://orcid.org/0000-0001-8341-7458
Abd-Elhamid, Tarek Hamdy
License Information

Text and Data Mining valid from 2021-07-15

Version of Record valid from 2021-07-15
More Information

Article History

Received: 18 March 2021

Accepted: 24 June 2021

First Online: 15 July 2021

Declarations

:

: This study was approved by the Ethics Committee of the Faculty of Medicine, Assiut University (No. IRB17300560).

: The authors declared that the final version of the manuscript has been reviewed, approved, and consented for publication.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below